Elizabeth Thiele is President of Late Phase Services & Outcomes Research.   Since joining ICON in 2002 she has held positions of progressing responsibility within the realm of business development including sales, proposals, contract management and business information.

 

Elizabeth has more than 25 years of experience in healthcare and pharmaceutical research, including business development and operations. Prior to joining ICON, she held various positions with contract research firms, public health entities, and educational institutions.  She has extensive experience in developing strategic relationships between pharmaceutical companies and external providers such as CROs. 

 

Elizabeth received both her Bachelor of Science and Masters degrees in Consumer Education with an emphasis in Health Sciences from Southeast Missouri State University.

Paul is Executive Vice President in the Late Phase and Outcomes Research division of ICON.

He was a co-founder of Oxford Outcomes in 1997 and was its Managing Director with responsibility for overall management of the group, business development, finance, and marketing until the company’s merger with ICON in early 2011. Prior to founding Oxford Outcomes, Paul was an urban and economic development consultant working on development projects in UK, North America, Ireland, Central and Eastern Europe. He has a BA (Honors) in Urban Studies and a Post-Graduate Diploma in Planning and Implementation from the University of Westminster.

Deb Nichols is a Business Development expert with more than twenty years experience in clinical research including late phase and outcomes research.  Deb joined ICON in 2001 with a focus on building the biotechnology market segment for ICON’s Clinical Research Division on the East Coast advancing to building and managing a sales team. 

Throughout her career at ICON, Deb held various positions with increasing responsibilities in sales and management which included leadership in the growth of ICON's strategic relationships with active participation in a variety of ICON-Sponsor Committees, along with training and management oversight of he US sales team.  Her current role as Vice President Business Development, ICON Late Phase and Outcomes Research, is instrumental in continuing to grow and strengthen the depth of ICON’s global service offerings in this specialized area. 

Prior to joining ICON, Deb held various sales related positions across a variety of spectrums including Payor, Prescriber and Clinical Research Recruitment and Investigators. In these positions Deb focused on epidemiology and outcomes research services supporting the development of standardized quality of life instruments as well as patient recruitment services in support of clinical trials.  Deb earned her BS degree in Marketing at the University of New Haven, CT
 

Michael is Senior Vice President, Strategic Planning and Proposals at ICON Late Phase & Outcomes Research in NY. 

This is a global role incorporating business development, operational integration, strategic planning and preparation of responses to client inquiries regarding functional and transformational change. Mike has more than 30 years of clinical research experience in a variety of Sponsor and CRO leadership and operational roles representing Phase I through IV. Mike has participated as an outsourcing professional in pharma companies and CROs giving him a balanced perspective of sponsor and provider roles. 

Prior to joining ICON, Mike’s experience includes:  Director, Outsourcing with Pfizer CDO; VP, Strategic Accounts with Kendle; President of ACER/Excel; Project Management at Ayerst and Whitehall divisions of American Home Products; and study coordinator at Raritan Bay Medical Center.  Mike holds a BS in Biological Sciences from Syracuse University.

Pat Steigerwald is Vice President, Project Operations & Delivery of ICON’s Late Phase and Outcomes Research division.  She has more than twenty-seven years of experience in health care and clinical research. Her background in oncology nursing and nursing management established her involvement in clinical research and Institutional Review Board activities.

 

Prior to joining ICON in 2010, Pat’s cumulative CRO experience spanned across Phase II-IV clinical research where she established a large client base of pharmaceutical, biotech and medical device customers for all phases of clinical research. She worked in two large CROs in various roles with increasing responsibilities, which included Global Vice President of Late Phase, Health Economics and Outcomes Research, Global Project Management Phase II-IV and Government Services. Pat provided leadership and global oversight for Phase II-IV Project Management. She developed and executed project management training programs to ensure compliance with global, regional and local regulatory requirements and facilitated strategy for development of global technology platforms for efficient delivery of all phases of clinical research. She provided leadership and global oversight for the development of late phase clinical research groups at two large CROs, establishing standardized global systems, processes and procedures to ensure competitive position in the global late phase market.

 

Pat earned her Bachelors of Science in Nursing and her Masters in Health Science degrees from Slippery Rock University.